6446 藥華藥


股價漲跌幅
202220212020
藥華藥39.0%216.0%-22.0%
0050-15.78%3.82%50.48%


現價可能漲跌幅 1合理價(本益比法)一年後目標價報酬率可能漲跌幅 2合理價(ROE法)
368.0 N/A N/A N/A N/A N/A N/A

  • 合理價(本益比法): 從 "一年後目標價" 回推得到
  • 可能漲跌幅 1: "合理價(本益比法)" 和 "現價" 的差距
  • 報酬率: 一年後可能的報酬率
  • 可能漲跌幅 2: "合理價(ROE法)" 和 "現價" 的差距
  • 推估價格僅供參考, Please Do Your Own Research

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近10年
202120202019201820172016201520142013
營業毛利率42.2933.0179.82-8.23106.4979.23-262.8955.1792.97
營業利益率-429.91-307.91-277.80-4020.77-22044.00-15506.70-7436.82-6465.05-831.05
折舊負擔比率33.6430.7043.79207.691475.001180.00483.33407.6947.22
稅前淨利率-428.17-349.57-275.49-3960.85-21618.50-15437.90-7362.16-6387.44-820.09
股東權益報酬率-68.81-63.10-35.67-35.07-22.58-34.07-79.07-47.42-44.28
資產報酬率-47.79-45.73-29.04-32.08-21.32-30.45-63.10-44.09-40.33
本業收入比100.3988.09100.83101.54101.95100.47101.06101.17101.35
業外獲益比-0.3911.91-0.83-1.54-1.95-0.47-1.06-1.17-1.35
無形資產佔淨值比3.974.003.310.570.000.000.000.000.00

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營業毛利率52.0456.5025.8619.6522.5948.50-10.0742.89-51.6970.34128.2594.69101.65-7.54-112.20-0.4649.59
營業利益率-221.24-250.50-763.89-626.44-638.55-227.14-404.89-169.04-40850.10-43.81-15951.10-295.85-791.83-1488.27-42730.90-19886.80-38186.20
稅前淨利率-214.84-233.37-760.72-623.17-699.42-285.13-460.75-158.69-41067.50-43.73-15888.10-291.62-783.68-1491.02-41558.10-19366.20-37545.50
本業收入比102.96107.33100.43100.5591.3679.7187.82106.7699.32100.00100.36101.49101.08100.00102.89102.88101.72
業外獲益比-2.96-7.33-0.43-0.558.6420.2912.18-6.760.68-0.00-0.36-1.49-1.080.28-2.89-2.88-1.72

現金流量-近10年 (1.避開自由現金流量近3年都小於0的公司 2.營運現金流量要大於稅後淨利,除非受到應收帳款和存貨影響 3.營運現金流量不應該都是流出)
202120202019201820172016201520142013
營運現金流量(百萬)-2462-1455-945-827-790-657-527-599-301
自由現金流量(百萬)-2540-1757-1183-1016-852-686-575-785-369
稅後淨利(百萬)-2811-1948-843-1040-872-845-853-853-593


現金流量-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營運現金流量(百萬)-799-551-524-658-730-745-307-236-166-310-132-235-267-202-215-215-195
自由現金流量(百萬)-793-563-559-682-737-834-424-276-222-429-152-301-299-252-296-248-220
稅後淨利(百萬)-541-887-700-541-683-832-617-208-292-88-275-202-278-358-242-208-232

成長能力-近10年 (營業利益和稅後淨利成長率要大於營收成長率)
202120202019201820172016201520142013
營收(百萬)6575573062645121372
營業利益(百萬)-2822-1716-849-1055-889-849-862-863-601
稅後淨利(百萬)-2811-1948-843-1040-872-845-853-853-593
EPS(完全稀釋)-10.80-8.04-3.85-4.76-4.01-4.14-4.50-4.54-3.40
營收成長率(%)17.9582.031076.92550.00-20.00-58.33-7.69-81.94N/A
營業利益成長率(%)N/AN/AN/AN/AN/AN/AN/AN/AN/A
稅後淨利成長率(%)N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS成長率(%)N/AN/AN/AN/AN/AN/AN/AN/AN/A

成長能力-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營收(百萬)25238092879829213413111992693624111
營業利益(百萬)-557-952-703-544-624-664-541-221-290-87-276-205-281-357-249-214-236
稅後淨利(百萬)-541-887-700-541-683-832-617-208-292-88-275-202-278-358-242-208-232
EPS(完全稀釋)-1.96-3.41-2.70-2.08-2.63-3.43-2.42-0.92-1.30-0.40-1.26-0.92-1.27-1.64-1.11-0.95-1.06
去年同期營收成長率(%)157.1430.14-31.34-33.599700.0046.736600.0089.86-97.22729.17100.006800.003500.000.000.000.00-
去年同期營業利益成長率(%)10.74-43.37-29.94-146.15-115.17-663.22-96.01-7.80-3.2075.63-10.844.21-19.070.000.000.00-
去年同期稅後淨利成長率(%)20.79-6.61-13.45-160.10-133.90-845.45-124.36-2.97-5.0475.42-13.642.88-19.830.000.000.00-
去年同期EPS成長率(%)25.480.58-11.57-126.09-102.31-757.50-92.060.00-2.3675.61-13.513.16-19.810.000.000.00-
較上季營收成長率(%)-33.68313.045.75-11.22-66.44117.912.2913000.00-99.509850.00-97.1091.6750.002300.000.000.000.00
較上季營業利益成長率(%)41.49-35.42-29.2312.826.02-22.74-144.8023.79-233.3368.48-34.6327.0521.29-43.37-16.369.320.00
較上季稅後淨利成長率(%)39.01-26.71-29.3920.7917.91-34.85-196.6328.77-231.8268.00-36.1427.3422.35-47.93-16.3510.340.00
較上季EPS成長率(%)42.52-26.30-29.8120.9123.32-41.74-163.0429.23-225.0068.25-36.9627.5622.56-47.75-16.8410.380.00

每月營收變化
年/月月增率(%)去年同期年增率(%)累計營收年增率(%)年/月月增率(%)去年同期年增率(%)累計營收年增率(%)
2022/4167.531078.8374.02019/12474248.0760.031065.16
2022/3140.02301.31157.722019/1150.0-84.153366.81
2022/1~2-14.8984.7784.772019/10-95.33-94.723692.72
2021/12-50.39190.5817.032019/932.15971.424576.74
2021/11431.513.014.242019/8-32.93140.214667.73
2021/1053.1810.645.132019/72015.62100.895089.26
2021/9-10.03-42.134.332019/6-99.95-52.236082.22
2021/8-8.48-21.514.562019/5125469.07856.566334.99
2021/736.54-27.9122.512019/4-99.79-60.994592.61
2021/6-23.46-46.640.412019/3193.055812.335656.07
2021/57.31-61.4587.482019/1~25979.725248.545248.53
2021/4-8.912675.377031.392018/128641.52745.82550.21
2021/3-2.276713.4513657.52018/11-50.09-47.52-4.65
2021/1~28.328432.628432.62018/10848.21225.763.31
2020/12-82.41-80.6883.372018/9-70.37-56.58-10.88
2020/11470.87520729.0390.372018/8-43.91-16.74-8.45
2020/10-19.88136750.0185.022018/7402.98104.24-7.6
2020/922.027871.33149.082018/6-92.28-87.5-16.68
2020/8-15.958533.03105.282018/5515.6188.378.68
2020/71.146788.6268.962018/4-68.38-77.36-36.56
2020/6-44.75143988.025.492018/3682.4534.747.86
2020/57627.420.84-18.522018/1~2-50.0-29.05-29.04
2020/4123.61863.63-94.962017/1261.18-43.9-26.27
2020/3408.42-98.16-98.02017/11209.81454.94-19.91
2020/1~2-28.03-97.52-97.512017/1026.3591.76-30.9

稅前淨利較去年同期
(百萬)(百萬)YoY(%)
000
(百萬)(百萬)YoY(%)
000
(百萬)(百萬)YoY(%)
000

EPS較上季
2022Q1(元)2021Q4(元)比率
-1.96-3.410.4252

應收帳周轉率和存貨周轉率-近10年
202120202019201820172016201520142013
應收帳款周轉率1.431.712.742.205.577.6523.724.1122.09
存貨周轉率0.601.150.430.62-0.010.041.130.120.10

應收帳周轉率和存貨周轉率-近20季
應收帳款周轉率
存貨周轉率

償債能力-近10年
202120202019201820172016201520142013
負債比0.310.290.240.120.060.050.340.110.04
金融負債(百萬)119155841001061121181130
營收淨額(百萬)6575573062645121372
利息保障倍數-280.94-234.95-111.02-655.87-496.04-446.28-448.05-856.390.00
長期銀行借款占稅後淨利比0.000.000.000.000.000.000.000.000.00

成本指標-近10年
202120202019201820172016201520142013
營收淨額(百萬)6575573062645121372
推銷費用(百萬)956379381751251014
管理費用(百萬)871598416250160142108105135
研發費(百萬)1273922640786683686714765530
推銷費用率(%)145.5168.0412.4265.381275.00500.0083.337.695.56
管理費用率(%)132.57107.36135.95961.544000.002840.00900.00807.69187.50
研發費用率(%)193.76165.53209.153023.0817075.0013720.005950.005884.62736.11

成本指標-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q1
營收淨額(百萬)25238092879829213413111992693624111
推銷費用(百萬)2253082381382732489036665171051111
管理費用(百萬)2053661741551761911859512794153888166616360
研發費(百萬)258493315267197366252147157127121165227284186150165
推銷費用率(%)89.2981.05258.70158.62278.5784.9367.1627.48600.003.02250.0024.6427.7820.83100.00100.001100.00
管理費用率(%)81.3596.32189.13178.16179.5965.41138.0672.5212700.0047.247650.00127.54225.00275.006100.006300.006000.00
研發費用率(%)102.38129.74342.39306.90201.02125.34188.06112.2115700.0063.826050.00239.13630.561183.3318600.0015000.0016500.00

財務健檢燈號
公司上市滿三年資本額10億以上股本形成中現金增資比率低於50%負債比率低於50%董監持股設質低於10%現金(含約當現金)占股本超過50%過去4季累積正營運現金流量過去4季ROE超過25%過去6個月的營收維持正的年成長率過去4季的EPS年增率是正數
6446-藥華藥OOXOOOXXOX
6年27.74億86.87%27.48%8.14%94.99%-2532百萬-52.32%


藥華藥熱門網頁

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。